Address: Edificio Scotiabank Inverlat,Piso 12 / Blvd M. Avila Camacho ,1 1009 México D.F.,Mexico
Tel: 52 55 5279 2900
Web: http://www.bakermckenzie.com/Mexico/
Operating in Mexico for nearly 50 years, we have gained a deep understanding of local law and extensive experience assisting domestic and multinational companies. With five offices and a team of more than 240 seasoned professionals that includes lawyers, accountants and economists, we can bring the right talent to any kind of transaction within or outside Mexico. We are regularly involved in major M&A matters, privatization of government-owned companies, and complex financial transactions involving multiple jurisdictions.
We understand the importance of sharing our knowledge and resources, so we encourage and support our professionals in engaging in pro bono and community service activities. We give legal assistance to various charitable institutions, business and health organizations, carry out fund-raising activities to help nonprofit organizations, and participate in activities aimed at promoting good business practice and improving legal knowledge.
We are regularly involved in major M&A matters, privatization of government-owned companies, and complex financial transactions involving multiple jurisdictions.
The regulatory framework in Mexico is in constant change, and pharmaceutical com-panies are struggling to comply. What sort of challenges are companies facing when deal-ing with COFEPRIS and what must…
The founder of this spin-off of the Autonomous University of the State of Morelos focusing on biologicals for human and veterinary use offers an overview of how the company came…
Latin America continues to be in the spotlight at Grünenthal. The managing director for Mexico explains how the company is strengthening its product portfolio, working with stakeholders to create more…
The president of CETIFARMA, the council created by the pharmaceutical industry in Mexico for ethics and transparency, discusses the tireless effort it has made to professionalize the compliance function in…
The Mexico country manager of the Swiss biopharmaceutical company discusses the recent restructuring process the subsidiary has been going through, the strategic importance of Mexico as a logistic and clinical…
The executive director of the board bringing together multinational and local drug manufacturers talks about the chamber’s goal to position the pharmaceutical industry as the most important manufacturing sector in Mexico,…
Exactly 10 years ago Mexico realized that its public healthcare provision was inadequate as it was based on a system of employment benefits. This left over 50 million Mexicans…
Marked socio-economic differences in Mexico are playing an important role in pushing the uptake of generics, and these issues are starting to affect multinational corporations (MNCs). MNCs are being forced…
“As Mexicans we must be prepared for a new stage of our country’s development”. These were the inspiring words of newly elected Mexican President Peña Nieto, who has promised…
A Regulatory Overview of the Mexican Healthcare market by ALEJANDRO LUNA FANDIÑO, Partner Olivares & Cia. Olivares & Cia T +52 55 5322 3080 F +52 55 5322 3001 E…
Beyond the bright lights of Mexico City’s Santa Fe and Polanco districts, roughly half of Mexicans lack access to quality healthcare or medicines. This presents a challenge for pharma companies…
In the late 1990s, Rodrigo Herrera Aspra wanted to commercialize a new anti-acne formulation, and was advised by a friend who was involved in the pharmaceutical industry to hire a…
As in many emerging countries, it is taking a while for Mexican legislation to catch up with the latest technologies. Alejandra Mendoza, general manager of Genzyme Mexico, says that regulation…
See our Cookie Privacy Policy Here
